(Q34417934)

2 August 2017

1 reference

title

The epidemiology of motor neuron diseases: a review of recent studies (English)

1 reference

2 August 2017

1 reference

Worms PM

1

1 reference

2 August 2017

1 October 2001

1 reference

Journal of the Neurological Sciences

2 August 2017

1 reference

2 August 2017

191

1 reference

2 August 2017

3-9

1 reference

2 August 2017

1-2

1 reference

Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Incidence of amyotrophic lateral sclerosis in three counties in western Washington state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Amyotrophic lateral sclerosis in Limousin (Limoges area, France)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Prognostic factors and survival in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Differential features of motor neuron disease mortality in Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Increasing mortality from amyotrophic lateral sclerosis in Norway?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

The Changing Mortality from Motor Neurone Disease and Multiple Sclerosis in England and Wales and the Republic of Ireland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Amyotrophic Lateral Sclerosis: An Epidemiological Study in the Province of Messina, Italy, 1976–1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Duration of amyotrophic lateral sclerosis is age dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Motor neuron disease in Cantabria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900630-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(01)00630-X

1 reference

2 August 2017

1 reference

PubMed ID

11676986